You are viewing: US Lateral Flow Assay Components Market analysis

The US Lateral Flow Assay Components Market was valued at $84.92 Million in 2025 and projected to reach to $102.39 Million by 2030, representing a compound annual growth rate of 3.8%. The US lateral flow assay components market is poised for steady growth through 2030, driven by sustained demand for rapid diagnostic solutions in clinical settings and consumer markets.

US Lateral Flow Assay Components Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Lateral Flow Assay Components Market Trends and Insights

  • The US market benefits from strong healthcare infrastructure, high adoption of point-of-care diagnostics, and significant investment in rapid testing technologies across clinical and home-use applications.
  • Demand in the US is driven by the prevalence of infectious diseases, chronic conditions requiring frequent monitoring, and regulatory support for rapid diagnostic solutions. Growth in the US lateral flow assay components market is supported by increasing consumer preference for convenient, at-home testing options and the expansion of telehealth services.
  • The US market encompasses critical components including membranes, reagents, and detection elements used in COVID-19, influenza, pregnancy, and other diagnostic tests.
  • Between 2025 and 2030, the US market will experience steady expansion as manufacturers innovate to improve sensitivity, specificity, and user experience while maintaining cost-effectiveness..

Key Market Statistics

  • CAGR (2025-2030) 3.8% CAGR
  • Market Size, 2025 ~USD 84.92 Million
  • Forecast, 2030 ~USD 102.39 Million
  • Country US

US Lateral Flow Assay Components Market Overview

Market Valuation :

The US lateral flow assay components market is valued at $84.92 million in 2025, with projected growth to $102.39 million by 2030, representing a steady 3.8% CAGR.

Healthcare Infrastructure Advantage :

Strong US healthcare infrastructure and high adoption rates of point-of-care diagnostics drive demand for lateral flow assay components across clinical laboratories, hospitals, and retail pharmacies.

Rapid Testing Technology Investment :

Significant investment in rapid testing technologies for both clinical and home-use applications positions the US market as a leader in point-of-care diagnostic innovation and deployment.

Growth Drivers :

Increasing demand for COVID-19 testing, influenza diagnostics, pregnancy tests, and infectious disease screening continues to fuel expansion of lateral flow assay component manufacturing and distribution in the US.

US Lateral Flow Assay Components Market Dynamics

  • The maturity of the US healthcare system, combined with ongoing investments in point-of-care testing infrastructure, supports consistent market expansion.
  • Regulatory support and FDA approvals for new diagnostic applications further strengthen market fundamentals. Key growth opportunities emerge from home-based testing adoption, multiplex assay development, and integration with digital health platforms.
  • The market will benefit from increased healthcare spending, aging population demographics, and continued emphasis on accessible diagnostics.
  • Competition among component manufacturers will drive innovation while maintaining healthy market dynamics through 2030..

Related Ecosystem

In Vitro Diagnostics

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Dna Microarrays
  • Assay Kits
  • Microarrays
Top Companies
  • ROCHE HOLDINGS AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Biomerieux s.a.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • JOHNSON & JOHNSON

      Key Takeaways

      • The US lateral flow assay components market is valued at $84.92 million in 2025 and will reach $102.39 million by 2030.
      • The US market is growing at a 3.8% CAGR, driven by demand for point-of-care diagnostics and at-home testing solutions.
      • Strong US healthcare infrastructure and regulatory support accelerate adoption of rapid diagnostic technologies.
      • Innovation in component sensitivity and user experience will sustain US market growth through 2030.

      Lateral Flow Assay Components Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment DRUG DEVELOPMENT & QUALITY TESTING (Application)
      Forecast Period 2025-2030
      Growth Rate CAGR of 4.4% from 2025 to 2030
      Largest Segment CLINICAL TESTING (Application)
      Market Size Base Year (Billions) ~USD 0.39 (2025)
      Revenue Forecast (Billions) ~USD 0.49 (2030)
      Segments Covered Product, Membrane Type, Pad Type, Technique, Application, Type, End User

      US Lateral Flow Assay Components Market Report Segmentation

      7 segment dimensions are covered across the global market.

      By Product

      • Membranes
      • Other Components
      • Pads

      By Membrane Type

      • Nitrocellulose Membranes
      • Other Membranes

      By Pad Type

      • Absorbent Pads
      • Conjugate Pads
      • Sample Pads

      By Technique

      • Competitive Assays
      • Multiplex Detection Assays
      • Sandwich Assays

      By Application

      • Clinical Testing
      • Drug Development & Quality Testing
      • Food Safety & Environmental Testing
      • Veterinary Diagnostics

      By Type

      • Cardiac Marker Testing
      • Cholesterol Testing/Lipid Profiling
      • Drug-Of-Abuse Testing
      • Infectious Disease Testing
      • Other Clinical Testing Applications
      • Pregnancy & Fertility Testing

      By End User

      • Medical Device Contract Manufacturing Companies
      • Medical Device Manufacturing Companies

      US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2023–2030

      Segment20232024202520262027202820292030CAGR (%)
      MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES48.0950.152.354.6957.3460.2463.4166.865
      MEDICAL DEVICE MANUFACTURING COMPANIES90.6993.0595.6498.48101.68105.17108.96113.093.4
      TOTAL138.78143.15147.94153.16159.02165.41172.37179.954

      Target Audience

      • Diagnostic Component Manufacturers : Manufacturers of lateral flow assay components need US-specific market data to optimize production capacity, plan product launches, and identify growth opportunities in clinical and consumer segments.
      • In Vitro Diagnostics (IVD) Companies : IVD manufacturers require detailed US market insights to develop competitive assay products, understand supply chain dynamics, and align sourcing strategies with market demand projections.
      • Healthcare Investment Firms : Private equity and venture capital investors need validated US market sizing and growth forecasts to evaluate investment opportunities in diagnostic technology companies and component suppliers.
      • Medical Device Distributors : US-based distributors and wholesalers require market intelligence to forecast demand, optimize inventory management, and identify high-growth product categories in point-of-care diagnostics.
      • Healthcare Policy & Regulatory Bodies : Government agencies and regulatory organizations use market data to understand diagnostic testing trends, assess healthcare accessibility, and inform policy decisions on rapid testing adoption.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise US market valuation ($84.92M in 2025) and verified 5-year forecast data to support investment decisions, business planning, and competitive positioning in the American lateral flow assay sector.
      • Regional Demand Insights : Understand US-specific drivers including healthcare infrastructure advantages, point-of-care adoption rates, and regulatory environment to tailor product development and market entry strategies effectively.
      • Competitive Benchmarking : Access US market dynamics and growth trajectories to benchmark performance against competitors, identify market gaps, and capitalize on emerging opportunities in rapid diagnostics.
      • Investment & Expansion Planning : Leverage detailed US market forecasts and segment analysis to justify capital allocation, manufacturing expansion, and distribution network investments in the American diagnostic components market.
      • Strategic Decision Support : Make informed decisions on product portfolio optimization, pricing strategies, and partnership opportunities based on comprehensive US market data and growth projections through 2030.

      Frequently asked questions

      What is the current size of the US lateral flow assay components market?

      The US lateral flow assay components market is valued at $84.92 million in 2025.

      What is the projected size of the US market by 2030?

      The US market is projected to reach $102.39 million by 2030.

      What is the growth rate of the US lateral flow assay components market?

      The US market is growing at a compound annual growth rate of 3.8% from 2025 to 2030.

      What are the main drivers of growth in the US market?

      Key drivers include increasing demand for point-of-care diagnostics, at-home testing adoption, strong healthcare infrastructure, and regulatory support for rapid diagnostic solutions in the US.

      Which applications dominate the US lateral flow assay components market?

      The US market is dominated by applications in COVID-19, influenza, pregnancy testing, and other infectious disease diagnostics.

      RESEARCH METHODOLOGY

      The study focused on key activities to estimate the current market size for the lateral flow assay (LFA) components market. Extensive secondary research was conducted to gather information on the industry. The next step involved validating these findings, assumptions, and size estimates with industry experts across the value chain through primary research. Various methods, such as top-down and bottom-up approaches, were used to calculate the total market size. Subsequently, market segmentation and data triangulation were employed to determine the sizes of segments and subsegments within the lateral flow assay components market.

      The four steps involved in estimating the market size are:

      Secondary Research

      The secondary research process involves extensively using secondary sources such as directories, databases (including Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings from companies, and publications from government agencies like the National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS). These sources are utilized to gather information for the global lateral flow assay components market study. They also help gather key details about the main players, market classification, and segmentation based on industry trends, down to the most detailed level, as well as significant developments related to market and technology perspectives. Additionally, a database of leading industry players was created using secondary data research.

      Primary Research

      In the primary research process, various sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. Primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from various companies and organizations operating in the LFAs market and the lateral flow assay components market. Primary sources from the demand side include medical device manufacturing companies and medical device contract manufacturer companies.

      The following is a breakdown of the primary respondents:

      Lateral Flow Assay Components Market

      Note 1: Other designations include sales managers, marketing managers, and product managers.

      Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      For the global market value, annual revenues were estimated based on revenue mapping of major product manufacturers and OEMs active in the worldwide lateral flow assay components market. All key service providers were identified at the global and/or regional, or country level. Revenue mapping for the respective business segments and sub-segments was conducted for the major players. The global lateral flow assay components market was split into various segments and sub-segments based on:

      • List of major players operating in the products market at the regional and/or country level
      • Product mapping of LFA components providers at the regional and/or country level
      • Mapping of annual revenue generated by listed major players from LFA components (or the nearest reported business unit/product category)
      • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
      • Summation of the market value of all segments/subsegments to arrive at the global lateral flow assay components market

      The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

      The research methodology used to estimate the market size includes the following:

      Lateral Flow Assay Components Market

      Data Triangulation

      After determining the overall market size using the method described above, the total market was divided into several segments. Data triangulation and market breakdown methods were used wherever applicable to complete the market segmentation process and obtain precise data for all segments and subsegments. The data was triangulated by analyzing various factors and trends from both demand and supply sides.

      Market Definition

      LFA components typically include membranes (such as nitrocellulose, polyvinylidene difluoride, nylon, or polyether sulfone membranes with immobilized antibodies) and pads (such as sample, conjugate, and absorbent pads) that are fixed to an inert backing material to create the assay. These components can be used for various applications, including clinical testing, food and beverage testing, and drug-of-abuse detection testing, among others.

      Stakeholders

      • Manufacturers and distributors of LFA components
      • Trade associations and industry bodies
      • Medical device contract manufacturing companies
      • Research and Consulting Firms
      • Venture Capitalists and Investors
      • Government Organizations

      Report Objectives

      • To define, describe, segment, and forecast the lateral flow assay components market by product, application, technique, end user, and region
      • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
      • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall lateral flow assay components market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
      • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
      • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
      • To study the impact of AI/Gen AI on the market, along with the macroeconomic outlook for each region

      Get the Full Lateral Flow Assay Components Market Report

      Full forecast, segment splits, and company analysis for all Lateral Flow Assay Components Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status